Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Research breakthrough identifies 291 genes associated with asthma

16.06.2003


Pathway identified to target for drug development



In one of the most significant breakthroughs in allergic diseases research in recent years, an international group of scientists led by researchers at Cincinnati Children’s Hospital Medical Center have discovered 291 genes associated with asthma. The Cincinnati Children’s scientists used gene chip analysis to identify these genes they refer to as "asthma signature genes," and they discovered a new and promising pathway involving one particular gene, arginase, to target for drug development.
Prior to this study, which is published in the July issue of the Journal of Clinical Investigation, scientists thought that only a dozen or so genes were implicated in asthma. The discovery that asthma involves the interplay of 291 genes "has tremendous therapeutic and diagnostic implications," says Marc Rothenberg, MD, PhD, director of Allergy and Immunology at Cincinnati Children’s and the study’s senior author.

"Each gene may represent a target for drug development," says Dr. Rothenberg. "But one gene in particular, arginase, regulates pathways that we think are critical in an asthmatic reaction. Regardless of the specific allergen, arginase seems to be involved. We hope to come up with a treatment for asthma by targeting arginase."



The study, which involved scientists in the United States, Canada and Australia, capitalized on both the human and mouse genome projects. Dr. Rothenberg and lead authors Nives Zimmermann, MD, and Nina King, MD, PhD, took lung tissue from mice with experimental models of asthma induced by different allergens. After analyzing the tissue with DNA microarrays, also known as gene chips, they discovered that the expression of 6.5 percent of the mouse genome was altered in an asthmatic lung.

"The identification of a series of asthma signature genes provides an unprecedented opportunity to fully understand the exact processes involved in asthma and other allergic diseases," says Dr. Rothenberg. "These results are significant because they present a completely new approach to treating and diagnosing asthma."

The Cincinnati Children’s researchers identified multiple new pathways involved in asthma. One such process involved the cellular machinery that processes arginine -- an amino acid normally consumed in the diet. Once processed in the body, arginine can be used to synthesize critical molecules such as growth factors, connective tissue proteins and nitric oxide.

In particular, the arginine transporter (the protein that carries it across the cell membrane) and the enzymes that act on it, arginase I and arginase II, were found to play an important role. The researchers found that the breakdown of arginine is shifted away from its normal pathway during asthma due to production of arginase. The researchers then compared these mouse DNA results to samples of asthmatic lung tissue taken from humans and showed that the arginase pathway was important in human disease.

"Because arginase is upstream in regulating pathways that are critical in allergic reactions, blocking the arginase pathway may benefit patients regardless of which gene is implicated in their asthma," says Dr. Zimmermann.

"With the publishing of these results, the asthma signature genes will now become available to the public over the worldwide web," adds Dr. Rothenberg. "It’s our hope that the release of these results will fuel the pharmaceutical industry, as well as other researchers, to take new approaches in asthma research," he says.

In recent years, the incidence of asthma and allergies has sky-rocketed for unclear reasons. More than 17 million Americans are currently estimated to have asthma, and more than 70 percent of people with asthma also suffer from allergies. Asthma affects more than 4.8 million children and adolescents under the age of 18. Asthma rates in children under the age of five increased more than 160 percent from 1980-1994.


Cincinnati Children’s Hospital Medical Center is a 373-bed institution dedicated to the pursuit of perfect health care. It is the only pediatric organization in the United States to receive the prestigious Pursuing Perfection grant from the Robert Wood Johnson Foundation. The Cincinnati Children’s Research Foundation ranks third nationally among all pediatric centers in research grants from the National Institutes of Health. The Cincinnati Children’s vision is to be the leader in improving child health, through patient care, research and education. Additional information about Cincinnati Children’s can be found at www.cincinnatichildrens.org.

Additional Contact:
Amy Caruso, 513-636-5637

Jim Feuer | EurekAlert!
Further information:
http://www.cincinnatichildrens.org/

More articles from Health and Medicine:

nachricht One gene closer to regenerative therapy for muscular disorders
01.06.2017 | Cincinnati Children's Hospital Medical Center

nachricht The gut microbiota plays a key role in treatment with classic diabetes medication
01.06.2017 | University of Gothenburg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Can we see monkeys from space? Emerging technologies to map biodiversity

An international team of scientists has proposed a new multi-disciplinary approach in which an array of new technologies will allow us to map biodiversity and the risks that wildlife is facing at the scale of whole landscapes. The findings are published in Nature Ecology and Evolution. This international research is led by the Kunming Institute of Zoology from China, University of East Anglia, University of Leicester and the Leibniz Institute for Zoo and Wildlife Research.

Using a combination of satellite and ground data, the team proposes that it is now possible to map biodiversity with an accuracy that has not been previously...

Im Focus: Climate satellite: Tracking methane with robust laser technology

Heatwaves in the Arctic, longer periods of vegetation in Europe, severe floods in West Africa – starting in 2021, scientists want to explore the emissions of the greenhouse gas methane with the German-French satellite MERLIN. This is made possible by a new robust laser system of the Fraunhofer Institute for Laser Technology ILT in Aachen, which achieves unprecedented measurement accuracy.

Methane is primarily the result of the decomposition of organic matter. The gas has a 25 times greater warming potential than carbon dioxide, but is not as...

Im Focus: How protons move through a fuel cell

Hydrogen is regarded as the energy source of the future: It is produced with solar power and can be used to generate heat and electricity in fuel cells. Empa researchers have now succeeded in decoding the movement of hydrogen ions in crystals – a key step towards more efficient energy conversion in the hydrogen industry of tomorrow.

As charge carriers, electrons and ions play the leading role in electrochemical energy storage devices and converters such as batteries and fuel cells. Proton...

Im Focus: A unique data centre for cosmological simulations

Scientists from the Excellence Cluster Universe at the Ludwig-Maximilians-Universität Munich have establised "Cosmowebportal", a unique data centre for cosmological simulations located at the Leibniz Supercomputing Centre (LRZ) of the Bavarian Academy of Sciences. The complete results of a series of large hydrodynamical cosmological simulations are available, with data volumes typically exceeding several hundred terabytes. Scientists worldwide can interactively explore these complex simulations via a web interface and directly access the results.

With current telescopes, scientists can observe our Universe’s galaxies and galaxy clusters and their distribution along an invisible cosmic web. From the...

Im Focus: Scientists develop molecular thermometer for contactless measurement using infrared light

Temperature measurements possible even on the smallest scale / Molecular ruby for use in material sciences, biology, and medicine

Chemists at Johannes Gutenberg University Mainz (JGU) in cooperation with researchers of the German Federal Institute for Materials Research and Testing (BAM)...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Plants are networkers

19.06.2017 | Event News

Digital Survival Training for Executives

13.06.2017 | Event News

Global Learning Council Summit 2017

13.06.2017 | Event News

 
Latest News

Quantum thermometer or optical refrigerator?

23.06.2017 | Physics and Astronomy

A 100-year-old physics problem has been solved at EPFL

23.06.2017 | Physics and Astronomy

Equipping form with function

23.06.2017 | Information Technology

VideoLinks
B2B-VideoLinks
More VideoLinks >>>